Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T19:37:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed descriptions of a clinical trial for brentuximab vedotin and the addition of new collaborators and a revision number.
    Difference
    14%
    Check dated 2025-04-16T14:32:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:21:25.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:18:29.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:40:24.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-02-17T14:42:17.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.